Insider Transactions in Q3 2023 at Atara Biotherapeutics, Inc. (ATRA)
Insider Transaction List (Q3 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 16
2023
|
Jill Henrich EVP, Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
3,346
-1.51%
|
$3,346
$1.65 P/Share
|
Aug 16
2023
|
Manher Joshi EVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,975
-1.85%
|
$6,975
$1.65 P/Share
|
Aug 16
2023
|
Anh Co Nguyen President and CEO |
SELL
Open market or private sale
|
Direct |
15,126
-2.54%
|
$15,126
$1.65 P/Share
|
Aug 16
2023
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
30,766
-2.2%
|
$30,766
$1.65 P/Share
|
Aug 16
2023
|
Amar Murugan EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,672
-1.59%
|
$8,672
$1.65 P/Share
|
Aug 16
2023
|
Eric J Hyllengren EVP, CFO and COO |
SELL
Open market or private sale
|
Direct |
8,186
-1.82%
|
$8,186
$1.65 P/Share
|